Arkolith/Insider Trading/NBSE/Form 4

Goldstein Dov A MD

DirectorNeuBase Therapeutics, Inc. (NBSE) · full profile →Form 4 · filed Jun 21, 2021
Net Buying
Open-Market Buys
$38K
Open-Market Sells
$0
Net Open-Market Flow
$38K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 18, 2021Buy(P)8K$4.75$38K30K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-21-083253) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML